Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

445
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
445

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic characterization and SNP analysis connect respiratory infections caused by <i>Mycobacterium intracellulare</i> with a pool facility.

Microbial genomics·2025
Same author

A case of severe <i>Mycobacterium thermoresistibile</i> pneumonia.

Respirology case reports·2024
Same author

The use of whole genome sequencing for tuberculosis public health activities in Australia: a joint statement of the National Tuberculosis Advisory Committee and Communicable Diseases Genomics Network.

Communicable diseases intelligence (2018)·2023
Same author

Whole-Genome Sequencing of SARS-CoV-2 from Quarantine Hotel Outbreak.

Emerging infectious diseases·2021
Same author

The Royal College of Pathologists of Australasia (RCPA) position statement on COVID-19.

Australian journal of general practice·2020
Same author

Emergence and divergence of major lineages of Shiga-toxin-producing Escherichia coli in Australia.

Microbial genomics·2019

Related Experiment Video

Updated: Dec 30, 2025

Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format
12:39

Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format

Published on: June 24, 2011

38.7K

Revised guidelines for Australian laboratories performing mycobacteriology testing.

Ivan Bastian1, Lisa Shephard1, Richard Lumb1

  • 1SA Pathology, PO Box 14, Rundle Mall, Adelaide SA 5000.

Communicable Diseases Intelligence (2018)
|January 16, 2020
PubMed
Summary
This summary is machine-generated.

Revised guidelines enhance tuberculosis (TB) laboratory practices in Australia. Updated biosafety, molecular diagnostics like Xpert MTB/RIF, and biorisk assessments improve TB control and patient care.

More Related Videos

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.5K
Identification of Mycobacterium Species by DNA Microarray Chip Method
06:27

Identification of Mycobacterium Species by DNA Microarray Chip Method

Published on: June 24, 2025

459

Related Experiment Videos

Last Updated: Dec 30, 2025

Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format
12:39

Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format

Published on: June 24, 2011

38.7K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.5K
Identification of Mycobacterium Species by DNA Microarray Chip Method
06:27

Identification of Mycobacterium Species by DNA Microarray Chip Method

Published on: June 24, 2025

459

Area of Science:

  • Medical Microbiology
  • Public Health Laboratory Science
  • Infectious Disease Diagnostics

Background:

  • Mycobacteriology laboratories are crucial for tuberculosis (TB) control through diagnostics, contact tracing, and international support.
  • Previous guidelines from 2006 outlined requirements for safe, high-quality work in Australian mycobacteriology laboratories.
  • These laboratories support TB control efforts in Australia and neighboring countries where TB is prevalent.

Purpose of the Study:

  • To revise and update the 2006 National Tuberculosis Advisory Committee (NTAC) laboratory guidelines for Australian mycobacteriology laboratories.
  • To incorporate advancements in biosafety, diagnostic technologies, and work practices.
  • To ensure continued high-quality and safe laboratory operations for effective TB control.

Main Methods:

  • Extensive peer review and consultation involving the Mycobacterium Reference Laboratory (MRL) network, Mycobacterium Special Interest Group (SIG) of the Australian Society for Microbiology (ASM), and other national bodies.
  • Integration of new biosafety standards (AS/NZS 2243.3:2010) and a biorisk assessment approach.
  • Inclusion of updated molecular diagnostic technologies such as MPT64-based immunochromatographic tests (ICTs) and the Xpert MTB/RIF assay.

Main Results:

  • Revised guidelines reflect updated biosafety standards and promote a biorisk assessment approach for laboratory procedures.
  • Recommendations allow for certain manipulations on positive TB cultures in enhanced PC2 laboratories based on biorisk assessment.
  • Integration of rapid molecular tests like MPT64 ICTs and Xpert MTB/RIF into laboratory workflows is advised.

Conclusions:

  • The revised guidelines provide updated standards for mycobacteriology laboratories, enhancing safety and diagnostic capabilities.
  • Adoption of new technologies and biorisk assessment will improve the speed and accuracy of TB diagnosis and patient management.
  • These updated guidelines supersede the 2006 publication and will be periodically reviewed for future technological advancements.